ClassID:

20331

A61K31/417 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles Imidazole-alkylamines, e.g. histamine, phentolamine

Recent Application in this class:
#301
20110237677
2011-09-29

Inhibitors

#302
20110217262
2011-09-08

Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability

#303
20110190398
2011-08-04

USE OF IMMUNOSUPPRESSANT COMPOUNDS IN A NEW INDICATION

#304
20110178147
2011-07-21

COMPOSITIONS AND METHODS FOR CONTROLLING PUPIL DILATION

#305
20110172434
2011-07-14

Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

#306
20110144082
2011-06-16

COMPOUNDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES

#307
20110137114
2011-06-09

Drug delivery system for treating erectile dysfunction

#308
20110130425
2011-06-02

Use of H3 Histaminergic Agonists for the Treatment of Addiction to Drugs of Abuse

#309
20110118267
2011-05-19

Method for treating psoriasis

#310
20110092551
2011-04-21

Dual-acting imidazole antihypertensive agents

#311
20110053975
2011-03-03

Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies

#312
20110020362
2011-01-27

Adrenergic stimulation mediates hypersensitivity by inducing nerve growth factor expression

#313
20100273805
2010-10-28

SULPHIDE BRIDGED DERIVATIVES AS MODULATORS OF MGLUR5 733

#314
20100256211
2010-10-07

Inhibition of Chronic Tissue Transplant Rejection

#315
20100222326
2010-09-02

New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders

#316
20100204284
2010-08-12

Hetero-substituted acetanilide derivatives as analgesic agents

#317
20100197750
2010-08-05

Preservation of ergothioneine

#318
20100137391
2010-06-03

Histamine H3 Agonist for use as Therapeutic Agent for a Lipid/Glucose Metabolic Disorder

#319
20100120851
2010-05-13

PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA

#320
20100113530
2010-05-06

S1P LYASE INHIBITORS FOR THE TREATMENT OF CEREBRAL MALARIA

#321
20100105748
2010-04-29

METHODS AND COMPOSITIONS FOR TREATMENT OF DRUG ADDICTION

#322
20090311315
2009-12-17

Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists

#323
20090257956
2009-10-15

Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation

#324
20090246174
2009-10-01

TREATMENT FOR CUTANEOUS T CELL LYMPHOMA

#325
20090214711
2009-08-27

DRINKING WATER FORMULATION AND METHOD AND ARTICLE RELATING TO SAME

#326
20090202518
2009-08-13

Treatment of sepsis and inflammation with alphaadrenergic antagonists

#327
20090197892
2009-08-06

ANHYDROUS COMPOSITIONS USEFUL FOR ATTAINING ENHANCED SEXUAL WELLNESS

#328
20090191278
2009-07-30

Homeopathy-based formulation

#329
20090143310
2009-06-04

Method of stimulating the motility of the gastrointestinal system using ipamorelin

#330
20090123536
2009-05-14

Oral Pharmaceutical Form of Losartan

#331
20090118335
2009-05-07

Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

#332
20090117131
2009-05-07

Pharmaceutical Composition for The Treatment or Prevention of Allergic Diseases, Use Thereof, and A Method for The Treatment or Prevention of Allergic Diseases

#333
20090087425
2009-04-02

Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease

#334
20090069348
2009-03-12

Use of Inhibitors of the Renin-Angiotensin System

#335
20090069322
2009-03-12

N-FORMYL HYDROXYLAMINE DERIVATIVES AS INHIBITORS OF BACTERIAL POLYPEPTIDE FORMYLASE FOR TREATING MICROBIAL INFECTIONS

#336
20090068180
2009-03-12

Compositions and methods for treating immunological and inflammatory diseases and disorders

#337
20090041800
2009-02-12

Methods for Treating Dependence

#338
20090035221
2009-02-05

Methods and Compositions for Treatment of Erectile Dysfunction

#339
20090023228
2009-01-22

Dual-acting imidazole antihypertensive agents

#340
20080312304
2008-12-18

Topical compositions containing metronidazole

#341
20080293735
2008-11-27

Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes

#342
20080287879
2008-11-20

System and method for treating erectile dysfunction

#343
20080269305
2008-10-30

Dual-acting antihypertensive agents

#344
20080268537
2008-10-30

PRIMARY N-HYDROXYLAMINES

#345
20080249088
2008-10-09

Topical Delivery of Antifungal Drugs

#346
20080200422
2008-08-21

Methods for reduction of adipose tissue mass

#347
20080194538
2008-08-14

Method for pain treatment

#348
20080175916
2008-07-24

Vessel enlargement by arteriogenic factor delivery

#349
20080153830
2008-06-26

Alpha and/or β-adrenergic antagonists and agonists to treat pain

#350
20080146627
2008-06-19

Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

#351
20080114057
2008-05-15

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE MUCOSAE, SKIN AND THE EYE

#352
20080090848
2008-04-17

Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides

#353
20080039507
2008-02-14

Prostamides for the treatment of glaucoma and related diseases

#354
20080015155
2008-01-17

Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye

#355
20080003209
2008-01-03

Method for treatment of neurodegenerative diseases and the effects of aging

#356
20070270448
2007-11-22

Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders

#357
20070238762
2007-10-11

Use of Antagonists of Hepatic Sympathetic Nerve Activity

#358
20070232675
2007-10-04

PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA

#359
20070203215
2007-08-30

Methods & Compositions For Enhancing Pharmaceutical Treatments

#360
20070179153
2007-08-02

Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

#361
20070054900
2007-03-08

4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy

#362
20070048335
2007-03-01

Methods for treating pain and hyperhidrosis

#363
20070021390
2007-01-25

Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

#364
20060276467
2006-12-07

Sodium channel modulators

#365
20060276433
2006-12-07

Hydrazone derivative

#366
20060247183
2006-11-02

Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye

#367
20060217429
2006-09-28

Use of inhibitors of the renin-angiotensin system

#368
20060198904
2006-09-07

Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens

#369
20060002913
2006-01-05

Use of histamine and related compounds to treat disorders affecting muscle function

#370
20050267208
2005-12-01

Nordihydroguaiartic derivatives for use in treatment of tumors

#371
20050245587
2005-11-03

Treatment of dyskinesia

#372
20050192327
2005-09-01

Use of inhibitors of the renin-angiotensin system

#373
20050192326
2005-09-01

Use of inhibitors of the renin-angiotensin system

#374
20050182108
2005-08-18

Hetero-substituted acetanilide derivatives as analgesic agents

#375
20050171192
2005-08-04

Use of histamine to treat bone disease

#376
20050154041
2005-07-14

Pharmaceutical composition consisting of a beta-3-adrenoceptor agonist and alpha-agonist

#377
20050143324
2005-06-30

Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye

#378
20050130966
2005-06-16

Sodium channel modulators

#379
20050090527
2005-04-28

Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis

#380
20050080056
2005-04-14

Ophthalmic formulations including selective alpha 1 antagonists

#381
20050049256
2005-03-03

Treatment of inflammatory autoimmune diseases with alpha-adrenergic antagonists and beta-adrenergic agonists

#382
20050038087
2005-02-17

Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

#383
20050038046
2005-02-17

Synergistic enhancement of cognitive ability

#384
17860682
2022-11-22

Chlorinated tetralin compounds and pharmaceutical compositions

#385
17585455
2022-12-27

Use of ergothioneine for extending lifespan or improving healthspan

#386
16377993
2020-03-31

Compositions and methods for diagnosis and treatment of neuromuscular disorders

#387
15378081
2017-10-24

Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvenation

#388
14800823
2016-03-15

Cycloalkyl-diamines for CNS disorders

#389
10799299
2015-03-17

Night vision composition